Analysis of efficacy and influencing factors of bevacizumab combined with chemotherapy in patients with non-small cell lung cancer

doi:10.3969/j.issn.1672-3384.2023.06.006

ZHANG Yu-jun, SHI Ya-fei, QI Shu-ya, YANG Jun, CHEN Wei, LI Guo-hui

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (6) : 41-48.

PDF(477 KB)

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (6) : 41-48. DOI: 10.3969/j.issn.1672-3384.2023.06.006

Original Article

Analysis of efficacy and influencing factors of bevacizumab combined with chemotherapy in patients with non-small cell lung cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(6): 41-48 https://doi.org/10.3969/j.issn.1672-3384.2023.06.006

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(477 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-03-16	2023-06-28
Issue Date
2023-06-28

Please choose a citation manager

Content to export